» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Name & Property Search

Name & Property Search

Search results for 'valeant pharmaceuticals international' | Search again
DeSoto Public Records:0
Shelby Public Records:0
Editorial:17
West Tennessee:0
Middle Tennessee:0
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

TNLedger Knoxville Edition subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. Valeant, a new business model and now, a new name -

NEW YORK (AP) — Valeant Pharmaceuticals, which fell under withering scrutiny after acquiring the rights to drugs and then drastically raising their prices, is changing its name.

The Canadian company said Tuesday that it will be called Bausch Health Companies Inc. starting in July.

2. Another drop for oil prices pulls stock indexes lower -

NEW YORK (AP) — Stock indexes sank Tuesday after yet another drop in the price of oil dragged down shares across the energy industry. Other areas of the market saw modest losses as investors wait to hear from the Federal Reserve, which began a two-day policy meeting on interest rates.

3. Ex-Valeant, Philidor execs charged with fraud, conspiracy -

NEW YORK (AP) Federal prosecutors are filing criminal charges against former executives of Valeant Pharmaceuticals and a mail-order pharmacy it helped to establish as the backlash against skyrocketing drug prices grows.

4. US stocks close broadly higher as investors eye election -

Investors remained in a buying mood on Election Day, sending U.S. stocks broadly higher and building on big gains from a day earlier.

Safe-play stocks such as utilities and phone companies were among the biggest gainers Tuesday. Energy companies were essentially flat.

5. Mylan boosts EpiPen patient programs, doesn't budge on price -

Mylan is bulking up programs that help patients pay for its EpiPen emergency allergy treatment after weathering heated criticism about an average cost that has soared over the past decade.

But the drugmaker didn't budge on its price hikes Thursday, which have drawn ire both in Congress and from families that have had to shell out increasingly large sums for the potentially life-saving treatment.

6. US stocks eke out small gains; Nasdaq sets record close -

U.S. stocks recovered from a late-afternoon slide to eke out small gains Tuesday, nudging the Nasdaq composite to its second record close in less than a week.

The three major stock indexes, all of which set new highs last Friday, rebounded from a slight decline on Monday.

7. Late sell-off leaves US stocks barely higher; oil rises -

NEW YORK (AP) — Stock indexes inched upward Tuesday, led by gains in energy companies as the price of oil closed above $50 a barrel for the first time in almost a year.

The market had been on track for its highest close since last July, but an afternoon stumble erased most of the early rally, leaving broad indicators with meager gains for the day.

8. US stocks mostly trade higher as energy sector rises -

NEW YORK (AP) — Stocks finished mostly higher Tuesday in another cautious day of trading. Energy companies climbed in tandem with the price of oil, but technology companies fell.

The market wavered between small gains and losses throughout the day. Chemicals companies made the biggest gains, led by DuPont, while energy companies benefited from higher oil prices. Health care stocks fell on more regulatory scrutiny of drug pricing. The Nasdaq composite index fell for the fourth day in a row.

9. US stocks slip as energy companies fall with oil prices -

NEW YORK (AP) — U.S. stocks slipped in quiet trading Monday as energy companies dropped with the price of oil. Metals and chemicals companies also fell. Company earnings remain weak, and Xerox and drugmaker Perrigo tumbled after reporting disappointing results and cutting their forecasts for the year.

10. Stocks shake off an early loss and end with slight gains -

Major U.S. stock indexes eked out modest gains on Monday, extending the market's winning streak into a fourth day.

Stocks wavered into the red at times before steadying in the late afternoon. The price of oil also veered lower at times, but ended higher.

11. US stocks end mixed, lower, amid drug company rout -

NEW YORK (AP) — Stocks ended mixed and mostly lower Tuesday, led by a steep decline in drug company shares as investors worried it will become harder for the companies to raise prices. Materials companies fell along with the price of precious metals.

12. Energy, mining stocks lead a decline on Wall Street -

U.S. stocks closed modestly lower on Monday as a deepening slump in crude oil prices pulled down energy and mining stocks on a lighter than usual day of trading.

Chevron fell 1.8 percent, the most in the Dow Jones industrial average. Consol Energy sank 9 percent.

13. Valeant subpoenaed over patient assistance program, pricing -

NEW YORK (AP) — Valeant Pharmaceuticals International Inc. says that federal prosecutors are seeking information on the drug developer's drug pricing, distribution and patient assistance program.

14. US stocks fall sharply on China growth worries -

NEW YORK (AP) — Ongoing worries about the health of the Chinese economy and another big sell-off in drugmakers pushed the stock market back toward its lowest level of the year.

Energy and raw material companies dropped on reports that industrial profits at Chinese companies fell sharply in August, heightening worries about a slowdown in the world's second-biggest economy. Health care stocks fell sharply as drugmakers extended a decline that began last week.

15. China worries weigh down US stocks in morning trading -

NEW YORK (AP) — Another sell-off in the Chinese stock market spread across global markets on Thursday. The declines pushed the Standard & Poor's 500 index into the red for 2015 in early-afternoon trading.

16. Valeant agrees to pay about $2.6B for Medicis -

TORONTO (AP) — Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.

17. Stocks end mixed on weak US economic reports -

NEW YORK (AP) — Stocks zigged and zagged after reports that the U.S. economy is weakening at a time when China and Europe are also slowing.

The Dow Jones industrial average closed down 54.90 points at 13,035.94 on Tuesday. Heavy equipment maker Caterpillar was the weakest stock in the Dow average, slipping 3 percent, or $2.67, to $82.66. The Standard & Poor's 500 index fell 1.64 points to 1,404.94.